PET PET
  • My Account
  • Subscribe
Become a Friend Donate
  • About Us
    • People
    • Press Office
    • Our History
  • Get Involved
    • Become a Friend of PET
    • Volunteer
    • Campaigns
    • Writing Scheme
    • Partnership and Sponsorship
    • Advertise with Us
  • Donate
    • Become a Friend of PET
  • BioNews
    • News
    • Comment
    • Reviews
    • Elsewhere
    • Topics
    • Glossary
    • Newsletters
  • Events
    • Upcoming Events
    • Previous Events
  • Engagement
    • Policy and Projects
      • Resources
    • Education
  • Jobs & Opportunities
  • Contact Us
  • About Us
    • People
    • Press Office
    • Our History
  • Get Involved
    • Become a Friend of PET
    • Volunteer
    • Campaigns
    • Writing Scheme
    • Partnership and Sponsorship
    • Advertise with Us
  • Donate
    • Become a Friend of PET
  • BioNews
    • News
    • Comment
    • Reviews
    • Elsewhere
    • Topics
    • Glossary
    • Newsletters
  • Events
    • Upcoming Events
    • Previous Events
  • Engagement
    • Policy and Projects
      • Resources
    • Education
  • Jobs & Opportunities
  • Contact Us
  • My Account
  • Subscribe
  • Privacy Statement
  • Advertising Policy
  • Thanks and Acknowledgements
PETBioNewsNewsEmbryonic stem cells self-destruct for the greater good

BioNews

Embryonic stem cells self-destruct for the greater good

Published 27 February 2013 posted in News and appears in BioNews 655

Author

Dr Greg Ball

Image by K Hardy via the Wellcome Collection. Depicts a human embryo at the blastocyst stage (about six days after fertilisation) 'hatching' out of the zona pellucida.
CC BY 4.0
Image by K Hardy via the Wellcome Collection. Depicts a human embryo at the blastocyst stage (about six days after fertilisation) 'hatching' out of the zona pellucida.

Human embryonic stem cells (hESCs) are primed to self destruct in response to DNA damage in the developing embryo, scientists have reported. The research found that hESCs are highly responsive to DNA damage in the early stages of development, and can commit suicide for the greater good...

Human embryonic stem cells (hESCs) are primed to self destruct in response to DNA damage in the developing embryo, scientists have reported. The research found that hESCs are highly responsive to DNA damage in the early stages of development, and can commit suicide for the greater good.

Embryonic stem cells give rise to every type of cell in the body and so it is vital that there are controls to stop any DNA damage being passed on throughout the embryo.

Dr Mohanish Deshmukh, who led the study at the University of North Carolina, said: 'Mutations that develop in these cells could be catastrophic for the developing organism, so it would make sense for these cells to be rapidly eliminated'.

The researchers used a chemotherapy drug to induce DNA damage in hESCs and found that almost all the cells died within five hours of exposure. This is much faster than fully matured cells, such as fibroblasts, which take 24 hours.

The hESCs were more resilient to other types of cellular stress that did not damage the DNA, suggesting they have a particular sensitivity to DNA damage.

The study, published in Molecular Cell, focused on the basic cell biology behind this sensitivity to DNA damage. Normally, a protein called Bax is switched on in cells undergoing this programmed cell death, which then directs the cell to die. However, they found that in hESCs it is switched on all the time, something previously unheard of.

'I was stunned', said Dr Deshmukh. 'I thought something was wrong. We spent a lot of time convincing ourselves that these cells were healthy and not actively dying'.

He explained that these cells do something 'very clever' - they keep Bax locked in a compartment of the cell called the Golgi, where it cannot switch the death process on. This means that if the DNA is damaged the cell can respond much more rapidly by releasing Bax from the Golgi.

This sensitive state appears to last only a few days during early development, as even 24 hours after the hESCs begin to differentiate into other cell types Bax is no longer switched on.

Dr Christopher Navara who studies embryonic stem cells at the University of Texas at San Antonio and was not involved in the study, described the research as 'convincing' in an email to The Scientist.

Related Articles

Image by K Hardy via the Wellcome Collection. Depicts a human embryo at the blastocyst stage (about six days after fertilisation) 'hatching' out of the zona pellucida.
CC BY 4.0
Image by K Hardy via the Wellcome Collection. Depicts a human embryo at the blastocyst stage (about six days after fertilisation) 'hatching' out of the zona pellucida.
Comment
30 January 2013 • 4 minutes read

Crystal ball gazing: human embryonic stem cells in 2012

by Dr Dusko Ilic

In the last few months of 2011, a couple of stories on human embryonic stem cells hit the headlines. Both were bad news for stem cell researchers...

Image by K Hardy via the Wellcome Collection. Depicts a human embryo at the blastocyst stage (about six days after fertilisation) 'hatching' out of the zona pellucida.
CC BY 4.0
Image by K Hardy via the Wellcome Collection. Depicts a human embryo at the blastocyst stage (about six days after fertilisation) 'hatching' out of the zona pellucida.
News
23 January 2013 • 2 minutes read

US embryonic stem cell researchers face logistical and funding difficulties

by Dr Antony Starza-Allen

A survey of over 200 human embryonic stem cell (hESC) researchers in the US has found almost four in ten respondents had experienced delays in obtaining cell lines and over one-quarter said they were unable to obtain a required cell line at all....

Image by K Hardy via the Wellcome Collection. Depicts a human embryo at the blastocyst stage (about six days after fertilisation) 'hatching' out of the zona pellucida.
CC BY 4.0
Image by K Hardy via the Wellcome Collection. Depicts a human embryo at the blastocyst stage (about six days after fertilisation) 'hatching' out of the zona pellucida.
News
10 January 2013 • 2 minutes read

Embryonic stem cell pioneers shut down trial

by Rosemary Paxman

A US drug company is abandoning its research into a novel paralysis treatment using embryonic stem cells, due to current economic conditions....

Image by Sílvia Ferreira, Cristina Lopo and Eileen Gentleman via the Wellcome Collection. Depicts a single human stem cell embedded within a porous hydrogel matrix (false colour).
CC BY 4.0
Image by Sílvia Ferreira, Cristina Lopo and Eileen Gentleman via the Wellcome Collection. Depicts a single human stem cell embedded within a porous hydrogel matrix (false-coloured cryogenic scanning electron micrograph).
News
10 January 2013 • 2 minutes read

Human embryonic stem cells can treat Parkinson's in rats

by Luciana Strait

Human embryonic stem cells have been used to treat a model of Parkinson's disease, rats and monkeys, pointing to a possible new way of treating the condition....

Leave a Reply Cancel reply

You must be logged in to post a comment.

« Fertility treatment only partly responsible for increase in birth defects

Data-Label The UK's Leading Supplier Of Medical Labels & Asset Labels

RetiringDentist.co.uk The UK's Leading M&A Company.

Find out how you can advertise here
easyfundraising
amazon

This month in BioNews

  • Popular
  • Recent
8 August 2022 • 2 minutes read

Placenta and organ formation observed in mouse embryo models

8 August 2022 • 2 minutes read

Lower hormone doses may improve IVF egg quality

8 August 2022 • 2 minutes read

Boosting muscle cell production of gene therapy proteins

1 August 2022 • 2 minutes read

First UK medical guidelines issued for trans fertility preservation

1 August 2022 • 2 minutes read

Male age has more impact on IVF birth rate than previously thought

8 August 2022 • 2 minutes read

Placenta and organ formation observed in mouse embryo models

8 August 2022 • 2 minutes read

Complex structures of the human heart bioengineered

8 August 2022 • 1 minute read

Brain tumour gene also linked to childhood cancers

8 August 2022 • 2 minutes read

Lower hormone doses may improve IVF egg quality

8 August 2022 • 2 minutes read

Boosting muscle cell production of gene therapy proteins

Subscribe to BioNews and other PET updates for free.

Subscribe
  • Twitter
  • Facebook
  • Instagram
  • LinkedIn
  • YouTube
  • RSS
Wellcome
Website redevelopment supported by Wellcome.

Website by Impact Media Impact Media

  • Privacy Statement
  • Advertising Policy
  • Thanks and Acknowledgements

© 1992 - 2022 Progress Educational Trust. All rights reserved.

Limited company registered in England and Wales no 07405980 • Registered charity no 1139856

Subscribe to BioNews and other PET updates for free.

Subscribe
PET PET

PET is an independent charity that improves choices for people affected by infertility and genetic conditions.

  • Twitter
  • Facebook
  • Instagram
  • LinkedIn
  • YouTube
  • RSS
Wellcome
Website redevelopment supported by Wellcome.

Navigation

  • About Us
  • Get Involved
  • Donate
  • BioNews
  • Events
  • Engagement
  • Jobs & Opportunities
  • Contact Us

BioNews

  • News
  • Comment
  • Reviews
  • Elsewhere
  • Topics
  • Glossary
  • Newsletters

Other

  • My Account
  • Subscribe

Website by Impact Media Impact Media

  • Privacy Statement
  • Advertising Policy
  • Thanks and Acknowledgements

© 1992 - 2022 Progress Educational Trust. All rights reserved.

Limited company registered in England and Wales no 07405980 • Registered charity no 1139856